Brian Shields: Should you monitor social KOL discussions in oncology?
Brian Shields, Founder of KOL Pulse AI, shared a post on LinkedIn:
“Should you monitor social KOL Discussions in Oncology?
What types of tools should you use to best understand the reach of these KOL conversations?
The ESOPEC Trial in GI Oncology was just published in NEJM and has generated significant discussion and debate in the Oncology community over the last year.
Who are the leaders of these discussions and what is their reach?
This is an impressive Social Graph Visualization of Key Opinion Leaders of this discussion and their connections with their network of peers. This was AI generated “on the Fly” with KOL Pulse AI technology.
Click here if you’d like a live demo.
Click here to demo our SABCS24 module on your own.
KOLs Highlighted: Nina Sanford, Krishan Jethwa, mark lewis, Daniel Catenacci, Sharlene Gill, Dr. Joseph McCollom.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023